Use of the erythromycin breath test for in vivo assessments of cytochrome P4503A activity and dosage individualization

Authors:

Abstract
Clinical Pharmacology & Therapeutics (2001) 70, 305–310; doi: 10.1016/S0009‐9236(01)45600‐1